Select: News

Feb 07, 2007 VaxGen Files Quarterly and Annual Reports for 2004 Jan 05, 2007 VaxGen Restructures to Reduce Spending and Retains Lazard to Pursue Strategic Options; James Panek Named CEO Following Resignation of Lance Gordon Jan 03, 2007 VaxGen Raises $51.3 Million Through Sale of Interest in Celltrion Dec 19, 2006 HHS Cancels VaxGen's Anthrax Vaccine Contract Dec 18, 2006 FDA Maintains Clinical Hold on VaxGen's Anthrax Vaccine Trial Nov 27, 2006 Government Sets New Deadline for VaxGen to Begin Next Clinical Trial Nov 16, 2006 Government Extends Deadline by Which VaxGen is Required to Resolve Clinical Hold Nov 04, 2006 VaxGen Receives Cure Notice On Anthrax Contract Nov 03, 2006 Next Clinical Trial of VaxGen's Anthrax Vaccine Delayed Nov 03, 2006 VaxGen to Present at Rodman & Renshaw 8th Annual Healthcare Conference and at CIBC World Markets 17th Annual Healthcare Conference  1   2   3   4   [5]  6   7   8   9   10  [ << ] [ < ] [ > ] [ >> ]